Ligne de temps

Catherine Blanc

Technicien(ne)

30 août 2025

publication

Lentiviral vector-based T-cell vaccines against Zika and yellow fever viruses

Lire plus

04 juil. 2025

publication

Optimized lentiviral backbone induces robust and diverse T cell immunity against neoantigens to counteract tumor heterogeneity.

Lire plus

21 juin 2024

publication

Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus.

Lire plus

10 juin 2024

publication

T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.

Lire plus

01 déc. 2023

publication

TMPRSS2 is a functional receptor for human coronavirus HKU1.

Lire plus

07 sept. 2023

publication

Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.

Lire plus

01 janv. 2023

publication

Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses.

Lire plus

14 sept. 2022

publication

A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity.

Lire plus

26 juil. 2022

publication

A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity.

Lire plus

27 avr. 2022

publication

An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.

Lire plus

07 déc. 2021

publication

Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.

Lire plus

29 juil. 2021

team

Laboratoire Commun Pasteur – TheraVectys

Lire plus

24 avr. 2018

publication

Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors

Lire plus

01 juin 2014

publication

Misidentification of Saprochaete clavata as Magnusiomyces capitatus in clinical isolates: utility of internal transcribed spacer sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry and importance of reliable databases.

Lire plus

Un petit guide pour l'utilisation de la recherche avancée :

Lentiviral vector-based T-cell vaccines against Zika and yellow fever viruses

Optimized lentiviral backbone induces robust and diverse T cell immunity against neoantigens to counteract tumor heterogeneity.

Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus.

T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.

TMPRSS2 is a functional receptor for human coronavirus HKU1.

Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.

Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses.

A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity.

A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity.

An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.

Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.

Laboratoire Commun Pasteur – TheraVectys

Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors

Misidentification of Saprochaete clavata as Magnusiomyces capitatus in clinical isolates: utility of internal transcribed spacer sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry and importance of reliable databases.